.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Deloitte
Merck
Baxter
Fish and Richardson
Farmers Insurance
Federal Trade Commission
McKinsey
Dow
Cerilliant

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018781

« Back to Dashboard

NDA 018781 describes HUMULIN N, which is a drug marketed by Lilly and is included in one NDA. It is available from three suppliers. There is one patent protecting this drug. Additional details are available on the HUMULIN N profile page.

The generic ingredient in HUMULIN N is insulin susp isophane recombinant human. There are thirty-eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the insulin susp isophane recombinant human profile page.

Summary for 018781

Tradename:1
Applicant:1
Ingredient:1
Patents:1

Suppliers and Packaging for NDA: 018781

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HUMULIN N insulin susp isophane recombinant human INJECTABLE;INJECTION 018781 NDA Eli Lilly and Company 0002-8315 0002-8315-17 1 VIAL in 1 CARTON (0002-8315-17) > 3 mL in 1 VIAL
HUMULIN N insulin susp isophane recombinant human INJECTABLE;INJECTION 018781 NDA Eli Lilly and Company 0002-8315 0002-8315-01 1 VIAL in 1 CARTON (0002-8315-01) > 10 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:INJECTABLE;INJECTIONStrength100 UNITS/ML
Approval Date:Oct 28, 1982TE:RLD:Yes
Patent:► SubscribePatent Expiration:Aug 9, 2024Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Argus Health
McKesson
Federal Trade Commission
Medtronic
Deloitte
Merck
Julphar
Farmers Insurance
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot